Scope: Enteroendocrine cell lines are routinely assayed in simple buffers at 20% oxygen to screen foods for bioactives that boost satiety hormone levels. However, in vivo, enteroendocrine cells are exposed to different phases of food digestion and function at low oxygen concentration, ranging from 7.5% in the stomach to 0.5% in the colon-rectal junction. 
Introduction
Healthy foods that increase feeling of fullness may reduce food intake and therefore help to manage weight over time. As such there has been considerable scientific interest in screening for food bioactives that modulate satiety signals in the gut. To be physiologically relevant, such in vitro screening platforms must closely resemble in vivo conditions.
Specialised endocrine L cells in the gastrointestinal tract (GI tract) respond to food ingestion by secreting a range of satiety hormones, including glucagon-like peptide 1 (GLP-1), cholecystokinin (CCK) and peptide YY (PYY). [1, 2] GLP-1 has effects on the ileal brake, gastric emptying, the hypothalamic circuits that regulate food intake and insulin secretion via its receptor GLP-1R. Secretion of GLP-1 in the GI tract occurs via elevation of cyclic adenosine monophosphate (cAMP) and/or cytoplasmic Ca 2+ concentrations, with both of these signalling pathways highly influenced by macronutrients in contact with L cells. [3, 4] Some studies show that carbohydrates are the main stimulants of GLP-1 secretion, whereas other studies favour proteins. [5, 6] Fatty acids (FAs) also play an important role in GLP-1 release via the G-coupled protein receptors GPR40 and GPR120. [7, 8] To date in vitro studies of GLP-1 production, secretion and the underlying mechanisms involved have been focused on individual ingredients and macronutrients rather than whole foods or digesta. [9] Enteroendocrine open type L cells are found throughout the length of the GI tract, with their numbers increasing towards the distal gut. [10, 11] As such, these cells are exposed to the lumen contents, from whole foods to digesta and to varying O 2 concentrations. O 2 level drops from 10 to 7.5% in the stomach to 1.5-0.5% in the colon-rectal junction. [12, 13] Together with nutrient content of the food, stage of food digestion and pathological conditions, O 2 tension most likely plays a significant role in GLP-1 production and secretion. [14] Physiological normoxia (2-5% O 2 in cellular environment) has attracted significant attention recently, as it affects many aspects of cell activities, including secretory function as metabolism switches from oxidative phosphorylation to anaerobic glycolysis with subsequent increase in glucose consumption. [15] [16] [17] Cell adaptation to the low O 2 is mediated by hypoxia inducible factor 1 (HIF-1). Its α subunit is rapidly degraded at normoxia, however at lower O 2 it stabilises and regulates expression of genes involved in cellular response. [18] Recently there is evidence that hypoxia decreases levels of proglucagon mRNA transcript and secreted GLP-1 in GLU Tag cells exposed to glucose and the cAMP stimulator forskolin (Fsk).
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The objective of this study was to investigate the effect of physiologically relevant O 2 concentrations (i.e. atmospheric hypoxia) on the production and secretion of GLP-1 from the murine enteroendocrine cell line, STC-1, in the presence of dairy components as they transit the GI tract. In epidemiological and intervention studies, consumption of dairy products has been associated with short-and long-term satiety [25] and has demonstrated positive effects on appetite suppression, energy intake and body weight. [26, 27] Fermented dairy beverages and yogurts have the highest satiety by visual analogue scales and/or by ad libitum energy intake. [28, 29] There is evidence that the satiety effect of individual milk ingredients is mediated via secretion of GLP-1. [30] For instance the major milk protein component, casein, bolsters GLP-1 secretion in vitro [31, 32] and in vivo. [33] Oleic and butyric acids, which represents 23.8 and 4.4% w/w of the total FAs in milk, increase GLP-1 exocytosis from the GLUTag cell line and from primary murine L cells. [7, 34, 35] Possible effects of milk disaccharide, lactose, on GLP-1 release have not been investigated, but digestion of lactose releases galactose and glucose, which are effective secretory stimulants of GLP-1. [3, 36] . We hypothesised that O 2 availability and hypoxia signalling pathways will impact on GLP-1 exocytosis in response to food, using enteroendocrine cells and dairy macronutrients as in vitro model system.
Experimental Section

Materials
Krebs-Ringer buffer was obtained from Sigma-Aldrich (Ireland). 100× Halt Protease and Phosphatase Inhibitor was purchased from Thermo Fisher Scientific (MSC, Ireland). 10× Gel Prep/Running buffer was sourced from Ambion (Applied Biosystems, USA). Mouse Metabolic Magnetic Bead Panel for active GLP-1 (#MMHMAG-44K) was from Millipore (Ireland). RNeasy RNA extraction kit, on-column DNase digestion kit and cell lysis buffer were from Qiagen (UK). Tetro cDNA synthesis kit was from Bioline (MSC, Ireland). LightCycler 480 SYBR Green I Master mix for tPCR was from Roche (Roche Products Ireland Limited). CellTitter One solution reagent and CellTox Green viability assay kit were from Promega (MyBIO, Ireland). Fluo-4 AM calcium indicator was from Molecular probes (UK). Direct cAMP ELISA kit and Fsk were from Enzo Life Sciences (UK). STC-1 was purchased from the American Tissue Culture Collection (ATCC code SD5482, supplied by LGC Standards, Teddington, UK). Casein (sodium caseinate from bovine milk, 95.6% protein on dry matter) was from Arrabawn (Ireland). Low fat Greek style natural yogurt (2.8 g fat, 5.6 g carbohydrates, 5.2 g protein per 100 g) was sourced from Tesco, Ireland. Oligonucleotide primers were synthesized by IDT (Belgium). LRF tripeptide was synthesised by microwave-assisted solid-phase peptide synthesis and purified using RP-HPLC. All other reagents were from Sigma-Aldrich. Filter tubes with threshold 10 kDa were from Satorius (Ireland). Other plastic ware was from Sarstedt (Ireland).
Cell Culture
Murine intestinal neuroendocrine tumour cell line STC-1 was cultured in DMEM containing 4.5 g L −1 of glucose and lglutamine, supplemented with 10% foetal bovine serum, 100 U mL −1 penicillin and 100 μg mL −1 streptomycin. Cells (between passage numbers [25] [26] [27] [28] [29] [30] [31] [32] [33] were grown at 37°C and 5% CO 2 up to a confluence 80-90%, media was changed every 2 d and cells were passaged every 2-3 d.
STC-1 Cell Exposure
STC-1 cells were seeded in 6-well plates at concentration 1. 6 cell well −1 were seeded in 24-well plates. The following day, media was aspirated and cells were washed once with modified Krebs-Ringer buffer (without bicarbonate but with 10 mM HEPES) and then pre-incubated in the same buffer for 1 h to acclimatise. Buffer was then aspirated and replaced with 1 mL (0.1 mL for 96-well plate) of macronutrients (100 μM oleic acid, 100 μM butyric acid, 0.5 mg mL −1 tripeptide LRF, 10 mg mL −1 casein, 40 mM glucose, 40 mM lactose) prepared in modified Krebs-Ringer buffer. Yogurt and yogurt digesta were diluted in the modified Krebs-Ringer buffer for a final concentration of 10 mg mL −1 . Phenol red-free DMEM, supplemented with 10 mM HEPES was used as a control for cell viability assays. For cAMP accumulation assays, modified Krebs-Ringer buffer was supplemented with 1 mM 3-isobutyl-1-methylxanthine; and 10 μM Fsk was used as a positive control. All non-sterile solutions were filter-sterilised (0.45 μm) prior to cell exposures for 4 h at 37°C.
Hypoxic and Normoxic Conditions
For the experiments at ambient (20%) O 2, standard 37°C incubator was used without CO 2 supply. For experiments under hypoxic atmosphere, cells were placed in a flushing hypoxia chamber (Billups-Rothenberg, Inc., USA), equilibrated at 0.5-7.5% O 2 (verified by Optech Platinum O 2 sensor, Mocon, USA) and inserted in a 37°C incubator. [37] 
GLP-1 (Active) Secretion
Following the incubation period, 10 μL of 100× Halt Protease and Phosphatase inhibitor were used to inactivate endogenous dipeptidyl peptidase IV activity, cell supernatants were collected in a 1.5 mL tubes and centrifuged at 900 × g and 4°C for 5 min to remove cellular debris. Supernatants were stored at −80°C prior to quantification of GLP-1 (active) levels. This was performed with Milliplex Map Kit and MagPix fluorescent detection system according to the manufacturer's instructions. Milliplex assay allows detection of active GLP-1 in the range 41-30 000 pg mL −1 , by www.advancedsciencenews.com www.mnf-journal.com using 5-parameter logistic curve fitting method and quantifying of samples according to the standard curve.
RNA Extraction and Real-Time PCR
After 4 h exposure to macronutrients, STC-1 cell monolayers were washed once with PBS buffer, pelleted, re-suspended in 0.35 mL of lysis buffer and stored at −80°C prior to RNA extraction. RNA extraction was performed with RNeasy Mini Kit, including on-column DNase digestion, following the manufacturer's instructions. Total RNA was quantified spectrophotometrically using the Nanodrop 1000 (Thermo Fisher Scientific, USA). RNA integrity was assessed by electrophoresis (Bio-Rad, USA) in a 1.5% glyoxyl agarose gel and glyoxyl buffer. 0 , where 0 corresponds to the control conditions and x to experimental conditions.
Cell Viability and Cytotoxicity Assays
After 2 h of cell exposure, 20 μL of Cell Titter One solution were added to wells, and STC-1 cells were incubated for another 2 h. Absorbance at 490 nm in each well was recorded with Synergy plate reader (BioTek, USA) and viability was calculated as percentage of positive control, which was measured in supplemented with 10 mM HEPES DMEM at 20% O 2 . For cytotoxicity assay, CellTox Green compound was added directly to the cell exposure solution (1:500 dilution in 50 μL per well) and fluorescence signal (ex. 485 nm, em. 520 nm) was measured after 4 h of incubation. Cell lysate was used as the positive control and assigned a value of 100% cytotoxicity.
cAMP Accumulation Assay
Intracellular cAMP levels were measured using a direct cAMP ELISA kit, according to manufacturers' instructions. After cell exposure to control or 10 mg mL −1 casein, supernatant was removed and cells were lysed with 0.2 mL of 0.1 M HCl for 10 min at room temperature. Cellular debris was removed by centrifugation at 900 × g for 5 min and samples were stored at −80°C prior to analysis. Results were generated at optical density of 405 nm using a Synergy plate reader. This ELISA kit allows detection of cAMP with sensitivity 0.39 pmol mL −1 , using standard curve for the range 0.78 -200 pmol mL −1 .
Intracellular Ca 2+ Assay
After 3 h exposure to control or 10 mg mL −1 casein in physiological normoxic/hypoxic conditions, cells were loaded with 2.5 μM Fluo-4 AM intracellular Ca 2+ probe and incubation was continued for another 1 h. Following this period, cell monolayers were washed two times with Krebs-Ringer buffer supplemented with 0.1 mM sulfinpyrazone to prevent changes in intracellular Ca 2+ levels and leakage of de-esterified indicator. Fluorescent signals of intracellular Fluo-4 AM probe were collected with Synergy plate reader, using excitation 488 nm and emission 520 nm.
Simulated Gastrointestinal Digestion
Simulated gastrointestinal digestion (SGID) of yogurt sample was performed based on the detailed protocol by Minekus et al. [44] . In short, 2 g of yogurt were mixed with simulated salivary fluid (1.25× concentrate), H 2 O, CaCl 2 and human salivary α-amylase for a final activity of 75 U mL −1 . The sample was mixed for >2 min at 37°C to mimic oral phase. Half of the volume was removed and inactivated (amylase activity) by reducing pH to 3 and re-adjusting to 7. Remaining bolus was mixed with simulated gastric fluid (1.25× concentrate) for the final ratio 50:50 v/v, CaCl 2 and porcine pepsin (2000 U mL −1 in the final mixture). The pH was reduced to 3 and water was added to dilute SGF. The mixture was incubated for 2 h at 37°C on rotor shaker to simulate gastric movement. Pepsin was inactivated in half of the volume by re-adjusting pH to 7. Remaining gastric chime was mixed with simulated intestinal fluid (1.25× concentrate) for the final ratio 50:50 v/v and neutralised to pH 7. Pancreatin was added according to its trypsin activity (100 U mL −1 in the final mixture). Bile salts were added to the final concentration of 10 mM, CaCl 2 was then added to reach 0.3 mM in the final mixture and pH was re-adjusted with 1 M NaOH. Simulated intestinal fluid was diluted with H 2 O and digestion was performed for 2 h at 37°C on rotor mixer. Pancreatic activity was stopped by 2.4 mg of 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride per 10 mL of digesta. Digesta was then diluted with distilled H 2 O at a ratio of 1:5. Trypsin was removed by filtration with centrifuge tube concentrator (molecular weight cut-off 10 kDa at 5000 × g, 10 min, 4°C). Aliquots of digesta after each phase (oral, gastric and intestinal) were immediately snap-frozen in liquid nitrogen for 30 s and stored at −80°C prior to STC-1 cell exposures.
www.advancedsciencenews.com www.mnf-journal.com
Data Assessment and Statistics
Cell viability, cytotoxicity and intracellular Ca 2+ data were obtained from two experimental repeats on different days and three technical repeats within each experiment. Active GLP-1, cAMP and PCR data were obtained from at least two experimental repeats on different days and two technical repeats within each experiment. Data are presented as means with SD as error bars. Statistical analysis was performed by paired samples t-test or oneway analysis of variance (ANOVA) in PASW statistics 18 software. Means without a common letter differ significantly from each other (p < 0.05).
Results and Discussion
Low O 2 Conditions Decrease GLP-1 Secretion from STC-1 Cells
To determine how GLP-1 secretion in response to individual dairy macronutrients is influenced by hypoxic conditions (0.5% O 2 in the atmosphere), protein (casein), carbohydrate (lactose) and fat (oleic acid) components of milk were selected. In vivo transit of food through the length of the GI tract is accompanied not only by changes in O 2 tension, but also results in the digestion of food and appearance of macronutrient breakdown products. To mimic the typical food components that L cells, located in the distal gut, would be exposed to, a sodium caseinate tripeptide LRF, glucose (the breakdown product of lactose) and butyric acid (a short chain FA that is found in milk, but also produced by gut bacteria [38] ) were also selected. The final concentrations for the food components were as previously described: 10 mg mL −1 casein, 40 mM lactose, 100 μM oleic acid, 0.5 mg mL
tripeptide LRF, 40 mM glucose and 100 μM butyric acid. [39] [40] [41] [42] Macronutrients were prepared in modified Krebs-Ringer buffer with buffering system based on 10 mM HEPES and without bicarbonate to maintain the required pH of 7.2-7.4 in the sealed flushing hypoxia chamber without CO 2 supply. [37] Hypoxic conditions were reached, as determined by a significant fold increases in HIF-1α mRNA transcript levels compared to ambient air conditions for all macronutrient exposures (data not shown). Low O 2 significantly decreased (p < 0.05) levels of active GLP-1 secreted from STC-1 cells in response to glucose, oleic acid, tripeptide and casein compared to ambient O 2 ( Figure 1A) . None of the nutrients tested, except intact casein, were capable of stimulating GLP-1 above levels observed for 11 mM glucose (modified Krebs-Ringer buffer control). This concentration of glucose is necessary for cell viability; however it may mask the stimulatory effects of other macronutrients. GLP-1 production, as measured by proglucagon mRNA transcript levels, was unaffected by hypoxia for all macronutrients tested except butyric acid, where mRNA transcript levels were significantly increased compared to ambient O 2 (p < 0.05) ( Figure 1B) . Treatment of STC-1 cells with glucose, tripeptide, butyric and oleic acids increased production of GLP-1 compared to the control in hypoxia, while no effect of treatments was observed in normoxia. This absence of correlation between production and secretion of active GLP-1 hormone suggests that regulation of its secretion in hypoxia occurs at posttranscriptional level. For instance other products of proglucagon, such as oxyntomodulin, GLP-2 and GLP-1 (1-37) may be released and the ratio of total to active GLP-1 (7-37) may differ. [6] Indeed, the significant stimulatory effect of casein could be a result of the release of active GLP-1 from secretory granules, without changes in the gene expression level. Kihira et al. reported that hypoxia conditions reduced proglucagon mRNA transcript level in GLUTag cells, but these observations were in response to cAMP stimulator Fsk in the presence of 2.5 mM glucose. [19] Similarly, PYY and CCK mRNA transcript levels were not significantly different (p > 0.05) in hypoxic conditions compared to ambient O 2 for each of the test food components except for butyric acid (1.86 and 1.82 vs. 1.42-and 1.39-fold change hypoxia vs. ambient O 2 ).
Secretion of GLP-1 by pGIP/Neo STC-1 and their viability in the presence of 0-10 mg mL −1 of whole casein, casein proteins and their hydrolysates were studied. [42] How the cells survive and proliferate in hypoxia for 4 h in the presence of casein and other food components was measured by CellTox cytotoxicity assay and Cell Titter cell proliferation assay. STC-1 cell line prefers the hypoxic environment with remarkably higher viability (p < 0.01) at 0.5% O 2 than at 20% O 2 for all treatments against a backdrop of modified Krebs-Ringer buffer (Figure 2A) . At the same time, cytotoxicity was comparable between ambient O 2 and hypoxic conditions with significant differences (p < 0.05) only observed for the treatments with glucose and casein ( Figure 2B ). Only treatment with casein in normoxia was able to improve cell viability compared to the control. This combined result indicates that, not surprisingly, the STC-1 cell line derived from the small intestine prefers hypoxia conditions. We would therefore suggest the use of hypoxic conditions for future studies where complex media is unsuitable. [5] 
GLP-1 Secretion over a Range of Oxygen Concentrations
O 2 concentration in the GI epithelium decreases distally, with reports of 7.5% in the stomach, 4.5% in the duodenum, 1.5% in the colon and small intestine and 0.5% in the colorectal junction of mice. [12] To study if GLP-1 release linearly depends on the O 2 concentration, STC-1 cells were exposed to O 2 levels resembling physiological conditions of the GI tract. As casein significantly increased active GLP-1 release above vehicle control and resulted in a large difference between hypoxic and ambient conditions, it was chosen to evaluate GLP-1 release at various concentrations of oxygen ( Figure 3A) . Secreted GLP-1 levels in response to intact casein depend on O 2 concentration, with an inverted bell curve response. The highest GLP-1 levels were observed at 20% O 2 (9.15 ± 0.03 ng mL −1 ) and the lowest levels at 7.5% O 2 (2.58 ± 0.04 ng mL −1 ) with hypoxic conditions resulting in 6.27 ± 0.15 ng mL −1 . Interestingly the GLP-1 levels in response to 11 mM glucose (control) varied from 0.58 to 1.49 ng mL −1 and were significantly higher at 7.5 and 20% O 2 than at 0.5 and 1.5% O 2.
Mechanism of Hypoxia Influence on GLP-1 Production
In vivo, enteroendocrine cells sense (i) amino acids and proteins via taste receptors T1R1/T1R3 and pept1/pept2 channels, [8] (ii) FAs via G-protein coupled receptors [7] and (iii) carbohydrates www.advancedsciencenews.com www.mnf-journal.com via sweet taste receptors T1R2/T1R3 and transporters GLUT1 or GLUT5. [43] Such interactions lead to electrogenic (Ca 2+ flux) and electroneutral (cAMP) governed release of GLP-1. Figure 3B details cAMP and intracellular Ca 2+ levels in STC-1 cells, exposed for 4 h to 10 mg mL −1 casein and modified Krebs-Ringer buffer as a control. Intracellular cAMP levels are significantly lower (p < 0.05) in response to intact casein under hypoxic conditions compared to normoxic conditions (8.65 and 10.92 pmol mL −1 , respectively). Interestingly, the ability of STC-1 cells to increase cAMP levels in response to the cAMP stimulator Fsk is significantly attenuated under hypoxia (60.7 pmol mL −1 in hypoxia vs.
146.3 pmol mL −1 cAMP in normoxia). This is in good agreement with Kihira et al. who observed a twofold decrease in ATP levels when GLUTag cells were exposed to Fsk under hypoxia. [19] In STC-1 cells, Ca 2+ levels in response to casein are not influenced by hypoxia (Figure. 3B ). In contrast, intracellular Ca 2+ levels rise in pulmonary arterial myocytes and in rat neonatal carotid body type I cells in response to hypoxia via generation of mitochondrial reactive oxygen species. [44, 45] The reduction in GLP-1 exocytosis in response to intact casein in hypoxic conditions may therefore be a symptom of the dampening of the cAMP signalling pathway rather than Ca 2+ involvement.
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Food Digestion in Study of Gut Hormone Regulation
To study the effect of physiological O 2 concentrations together with different phases of food digestion on enteroendocrine secretion of active GLP-1, commercially available yogurt (2.8 g fat, 5.6 g carbohydrates, 5.2 g protein per 100 g) was subjected to oral, gastric and intestinal SGID. [46] STC-1 cells were then incubated at 7.5% O 2 to represent typical conditions for orally digested food, 4.5% O 2 for gastric and 1.5% O 2 for intestinal digestas. Secreted GLP-1 levels in response to yogurt digestas compared to whole yogurt are detailed in Figure 4A . GLP-1 levels secreted in response to oral, gastric and intestinal yogurt digestas at their matching O 2 concentrations ranged from 4.41 to 21.62 ng mL −1 , with levels for gastric yogurt digesta at 4.5% O 2 significantly higher than for either oral or intestinal digesta samples (p < 0.05). In contrast, GLP-1 levels secreted in response to whole yogurt at different O 2 concentrations had a narrower range from 6.47 to 8.08 ng mL −1 . Interestingly, STC-1 cells exposed to intestinal yogurt digesta at 1.5% O 2 secreted significantly lower levels (p < 0.05) of GLP-1 than any of the other test samples including whole yogurt. GLP-1 levels in response to yogurt digesta at each SGID stage with corresponding O 2 concentration were significantly different (p < 0.05) compared to levels with yogurt at 20% O 2 (shown with dashed line).
The density of L cells increases from duodenum to colon, as O 2 concentration decreases. [11] Theoretically predicted efficiency of GLP-1 production was calculated from the GLP-1 levels obtained at each physiological condition ( Figures 3A and 4A ) as a function of the predicted number of cells at each location within the GI tract. [10, 11] Limitations of this theoretical model include the use of STC-1 cell monolayer versus heterogeneous 3D structure of the GI tract and the difficulty to predict sensitivity of L cells to treatment and absorption of nutrients at different locations of GI tract. However, the model benefits from including O 2 concentration and the stage of food digestion as factors, influencing GLP-1 secretion. This model predicts that yogurt digesta would be a more potent stimulant of GLP-1 secretion than glucose in the gut and peak levels of secreted GLP-1 would occur in the ileum and colon ( Figure 4B ). [11] Different superscript letters (generated with one-way ANOVA test) indicate significant difference (p < 0.05) in active GLP-1 secretion within an O 2 concentration. Asterisks indicate significant differences for each treatment between normoxic and hypoxic conditions (*p < 0.05, **p < 0.01).
Concluding Remarks
In conclusion, intact casein can increase levels of GLP-1 secretion from glucose-stimulated STC-1 cells, probably via intracellular Ca 2+ signalling. At low oxygen concentrations, this secretion is attenuated possibly by a decrease in cAMP levels. Exposing enteroendocrine STC-1 cells to oxygen concentrations and food digesta relevant to specific GI locations significantly alters the level of active GLP-1 secreted. As yogurt transits the gut, 4.5% oxygen and digesta of the gastric phase generate peak GLP-1 levels. Transcription of satiety hormones is not affected by hypoxia for variety of stimulations with macronutrients except for butyric acid, which is produced by the bacteria of the hypoxic colon. Where cells are assayed in buffers, cell viability is an issue and can be improved by the use of hypoxic conditions. Altogether, physiological O 2 levels and food digestion have significant influence on gut hormone secretion and their impacts on satiety hormones warrant further investigation.
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